Cargando…
The adjuvant GLA-AF enhances human intradermal vaccine responses
Adjuvants are key to shaping the immune response to vaccination, but to date, no adjuvant suitable for human use has been developed for intradermal vaccines. These vaccines could be self-administered and sent through the mail as they do not require long needles or technical expertise in immunization...
Autores principales: | Carter, Darrick, van Hoeven, Neal, Baldwin, Susan, Levin, Yotam, Kochba, Efrat, Magill, Al, Charland, Nathalie, Landry, Nathalie, Nu, Khin, Frevol, Aude, Ashman, Jill, Sagawa, Zachary K., Beckmann, Anna Marie, Reed, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136895/ https://www.ncbi.nlm.nih.gov/pubmed/30221194 http://dx.doi.org/10.1126/sciadv.aas9930 |
Ejemplares similares
-
Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes
por: Kochba, Efrat, et al.
Publicado: (2016) -
Intradermal injection of lidocaine with a microneedle device to provide rapid local anaesthesia for peripheral intravenous cannulation: A randomised open-label placebo-controlled clinical trial
por: Rzhevskiy, Alexey, et al.
Publicado: (2022) -
GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
por: Clegg, Christopher H., et al.
Publicado: (2014) -
Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin
por: Golombek, Sonia, et al.
Publicado: (2018) -
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults
por: Sagawa, Zachary K., et al.
Publicado: (2023)